-
News | 2020.10.05
New Edition Of The Free On-Line Mooc Malaria
Malaria remains a major public health problem in many low and middle-income countries in the tropics. In 2018, WHO estimates that there were around 228 million cases of malaria that caused 405,000 deaths, primarily in sub-Saharan Africa. While the intensive application of currently available malaria control tools has greatly reduced malaria transmission in many parts of the world where malaria is...
-
Document de presse | 2020.10.08
AIDS: Furthering Knowledge of Natural HIV Infection Control Mechanisms
A further step has just been taken in understanding the mechanisms that allow some individuals to control HIV infection without treatment.A research team led by Dr. Asier Sáez-Cirión (Institut Pasteur) and Dr. Bruno Vaslin (IDMIT[1], CEA-Inserm-Université Paris Saclay) observed for the first time that the antiviral activity of CD8+ T cells of "controller" macaques infected with the simian...
-
News | 2020.10.12
A feedback on 10 months of mobilization of the Institut Pasteur against covid-19
On Thursday, October 8, 2020, the Institut Pasteur in Paris organized an exceptional digital conference to review 10 months of mobilization against Covid-19, a force still in action for global health. Four experts from the Institut Pasteur were present to talk about the epidemic, tests, treatments, vaccines, scientific modelling, and answer questions from Internet users. This conference is...
-
News | 2020.10.13
Hepatitis B: new guidelines for treating HBV-positive pregnant women
Hepatitis B is a viral infection that can be fatal. Most chronic forms are caused by mother-to-child transmission. To avoid this transmission, the World Health Organization (WHO) decided to add new recommendations to its existing guidelines. Yusuke Shimakawa, an expert at the Institut Pasteur in Paris, was given the task of producing two systematic reviews to help determine the nature of the new...
-
News | 2020.10.11
A sentinel for health monitoring #podcast
For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), listen to a podcast in French. Mathieu Vidard, presenter of "La Terre au carré" on France Inter (major French public radio channel and part of Radio France), discusses with two distinguished scientists from the Institut Pasteur: Christophe d’Enfert, scientific director and ...
-
News | 2020.10.10
The brain, this great unknown #podcast
Neurology is an interdisciplinary field, in which research has evolved significantly in recent decades. At the Institut Pasteur, research is conducted on many subjects related to the brain such as degenerative diseases, memory, brain connectivity or sensory deficits. For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), a podcast in French has been recorded. Two '...
-
News | 2020.10.09
Fighting Cancer #podcast
In 2018, 40,000 new cases of cancer were recorded in France, where this disease is the leading cause of death. Within the Institut Pasteur, more than 50 interdisciplinary teams are working on the subject. For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), a podcast in French has been recorded. Two Pasteurian researchers, Sandrine Etienne-Manneville and Ludovic Deriano,...
-
News | 2020.10.08
Antibiotics, when bacteria become resistant #podcast
Antimicrobial resistance could become the leading cause of death in the world, with 10 million deaths in 2050, if nothing is done to prevent it. Today, 400,000 people die each year because of antibiotic resistance. The Institut Pasteur has made the study of bacterial resistance and the fight against resistant bacteria one of its priorities. On the occasion of Pasteurdon 2020 (the Institut...
-
News | 2020.10.07
Emerging diseases and Covid-19 #Podcast
Institut Pasteur's expertise in infectious diseases has made it one of the major players in research against Covid-19. For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), a podcast in French has been recorded. Two Pasteurian researchers, Sylvie van der Werf and Arnaud Fontanet, talk about this pandemic and the Institut Pasteur's actions to fight the virus. They also...
-
Article | 2020.10.14
Covid-19: vaccine against SARS-CoV-2 infection, using the measles vector
Phase I testing in humans for the Institut Pasteur's SARS-CoV-2 vaccine candidate using the measles vector was lauchned in August 2020 in France and Belgium. Following the intermediate results of the Phase I clinical trial, the Institut Pasteur is stopping (January, 2021) development of the vaccine candidate based on the measles platform.
